American Journal of Obstetrics & Gynecology
Volume 202, Issue 3 , Pages 221-231, March 2010

Menstrual cycle-related exacerbation of disease

  • JoAnn V. Pinkerton, MD

      Affiliations

    • Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA
    • Corresponding Author InformationReprints: JoAnn Pinkerton, MD, University of Virginia, Department of Obstetrics and Gynecology, PO Box 801104, Northridge Ste. 104, Charlottesville, VA 22908
  • ,
  • Christine J. Guico-Pabia, MD, MBA

      Affiliations

    • Wyeth Research, Collegeville, PA
  • ,
  • Hugh S. Taylor, MD

      Affiliations

    • Yale University, New Haven, CT

Received 20 March 2009; received in revised form 13 July 2009; accepted 23 July 2009.

Exacerbation of common medical and mental health disorders at specific phases of the menstrual cycle is a prevalent phenomenon. Although the precise cause is unclear, studies implicate complex interactions between the immune and neuroendocrine systems. The menstrual cycle also is a trigger for the onset of depressive disorders, including premenstrual dysphoric disorder, a disorder specific to the luteal phase of the menstrual cycle, and depression associated with the transition to menopause. This article discusses common mental health problems exacerbated by the menstrual cycle, with a particular focus on premenstrual dysphoric disorder and perimenopausal depression. Throughout the reproductive lifespan, routine screening and assessment for the presence of common psychiatric disorders are critical for accurate diagnosis and provision of effective treatment. Management options include referral or consultation with a primary care provider or psychiatrist; treatment options for premenstrual dysphoric disorder and perimenopausal depression include pharmacotherapy with antidepressant agents and/or psychotherapy. Hormones may be helpful.

Key words: exacerbation, major depressive disorder, menstrual cycle, premenstrual dysphoric disorder, transition to menopause

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was sponsored by Wyeth Research, Collegeville, PA.

 Dr Pinkerton has received research Grants from Wyeth, Solvay, Lilly and Pfizer. She has served as consultant for Wyeth, Novo Nordisk, Eli Lilly, and Amgen. Dr Guico-Pabia has been an employee for Wyeth Research, Collegeville, PA. Dr Taylor has been on the Speaker's Bureau and received research Grant support from Wyeth. Per the International Committee of Medical Journal Editors (ICMJE) “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication”, all authors had a significant role in the development of the initial outline, contributed to the writing and preparation of the publication, and approved the final version to be submitted for peer review and, ultimately, published.

PII: S0002-9378(09)00854-0

doi:10.1016/j.ajog.2009.07.061

American Journal of Obstetrics & Gynecology
Volume 202, Issue 3 , Pages 221-231, March 2010